最新上傳 | 台灣泌尿科醫學會E-School

MP07-06: Risk factors for highly recurrent bladder neck contracture after transurethral resection/enucleation of prostate for benign prostate hyperplasia

2021-05-24

MP07-05: Comparison of Thulium laser (VelaTM XL) enucleation of prostate with bipolar transurethral enucleation of the prostate (B-TUEP) of outcome and quality of life

2021-05-24

MP07-04: Post-Operative Change of PSA as an Outcome Predictor in BPH Patients Receiving Transurethral Laser Surgery

2021-05-24

MP07-03: The role of Aptamers in regulation of prostate inflammatory process

2021-05-24

MP07-02: The impact of androgen deprivation therapy on lower urinary tract symptoms in prostate cancer patients - a single institute experience

2021-05-24

MP07-01: Difference of electron microscopic findings in IC/BPS with different cystoscopic characteristics following hydrodistention

2021-05-24

MP06-10: Perioperative Outcomes of Robotic Assisted Radical Prostatectomy in Elder Patients

2021-05-24

MP06-09: Anal sphincter length and power are associated with early continent after radical prostatectomy

2021-05-24

MP06-08: Serum vitamin D levels in females with urinary incontinence: a meta-analysis of observational trials

2021-05-24

MP06-07: XX male syndrome : A rare cause of male infertility, case analysis in a tertiary fertility service

2021-05-24

MP06-06: Comparing the outcomes and effectiveness of robotic-assisted sacrocolpopexy and laparoscopic sacrocolpopexy in the treatment of pelvic organ prolapse

2021-05-24

MP06-05: The video urodynamic characteristics in SCI patients with different injury level and bladder condition

2021-05-24

MP06-04: Urethra-sphincter complex volume predictive of residual diverticulum after diverticulectomy

2021-05-24

MP06-03: Routine use of prophylactic metoclopramide after transperitoneal robotic-assisted radical prostatectomy: really needed?

2021-05-24

MP06-02: The senhance robotic system is feasible in oncologic and non-oncologic urologic surgeries: initial experiences and troubleshooting of new system

2021-05-24

MP06-01: Impact of obesity on the outcome of prostate cancer post robot-assisted radical prostatectomy

2021-05-24

MP05-10: Results of bevacizumab plus erlotinib in patients with metastatic type 2 papillary renal cell cancer - experience in Taipei Veterans General Hospital

2021-05-24

MP05-09: Glutathione s-transferase Mu 5 plays anti-tumor activity in bladder cancer cells

2021-05-24

MP05-08: Anti-cancer effects and tumor marker role of glutathione s-transferase mu 5 in human bladder cancer

2021-05-24

MP05-07: Hyperthermia inhibits chemotherapeutic drug resistance of bladder cancer cells through epithelial mesenchymal transition down-regulation

2021-05-24

MP05-06: External validation of Likert scale for predicting non-muscle invasive bladder cancer, KCGMH experience

2021-05-24

MP05-05: Cadherin-11 regulates cell pyroptosis and induces anti-tumor immunity through PD-L1 in bladder cancer

2021-05-24

MP05-04: The attenuation of chloroquine and hydroxychloroquine on the invasive potential of bladder cancer by targeting MMP-2 expression

2021-05-24

MP05-03: Small non-coding microRNAs (miRNAs) target hepatoma-derived growth factor (HDGF) as a novel therapeutic strategy for urothelial carcinoma

2021-05-24

/ 131